Mohamed A, Nagah Amer N, Osama N, Hafez W, Abdelrahman Ali A, Shaheen M
Noncoding RNA Res. 2025; 10():262-268.
PMID: 39844891
PMC: 11751402.
DOI: 10.1016/j.ncrna.2024.12.003.
Tate A, Rao G
Biomolecules. 2024; 14(8).
PMID: 39199336
PMC: 11352362.
DOI: 10.3390/biom14080948.
Ivan E, Teresa E, Catalina L, Alberto Francisco R, Elena R
Endocr Metab Immune Disord Drug Targets. 2024; 24(14):1640-1650.
PMID: 38415492
DOI: 10.2174/0118715303284893240215070923.
Patel J, Carr K, Rice M
Biomolecules. 2023; 13(3).
PMID: 36979453
PMC: 10046598.
DOI: 10.3390/biom13030518.
Sheibani M, Jalali-Farahani F, Zarghami R, Sadrai S
Curr Pharm Des. 2022; 29(1):37-47.
PMID: 36518037
DOI: 10.2174/1381612829666221214122802.
Comparison of area under the curve in various models of diabetic rats receiving chronic medication.
Liu K, Niu C, Tsai J, Yang C, Peng W, Niu H
Arch Med Sci. 2022; 18(4):1078-1087.
PMID: 35832712
PMC: 9266878.
DOI: 10.5114/aoms.2019.91471.
Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches.
Shanak S, Bassalat N, Barghash A, Kadan S, Ardah M, Zaid H
Evid Based Complement Alternat Med. 2022; 2022:2832889.
PMID: 35356248
PMC: 8958086.
DOI: 10.1155/2022/2832889.
Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network.
Tomar M, Somvanshi P, Kareenhalli V
Mol Biol Rep. 2022; 49(6):5017-5028.
PMID: 35079935
DOI: 10.1007/s11033-022-07175-w.
Driver versus navigator causation in biology: the case of insulin and fasting glucose.
Diwekar-Joshi M, Watve M
PeerJ. 2020; 8:e10396.
PMID: 33365205
PMC: 7735078.
DOI: 10.7717/peerj.10396.
Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity.
Duszka K, Gregor A, Guillou H, Konig J, Wahli W
Cells. 2020; 9(7).
PMID: 32708786
PMC: 7407644.
DOI: 10.3390/cells9071708.
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations.
Janssen J
Cells. 2020; 9(4).
PMID: 32252327
PMC: 7226833.
DOI: 10.3390/cells9040862.
Deciphering the expression dynamics of ANGPTL8 associated regulatory network in insulin resistance using formal modelling approaches.
Siddiqa A, Ahmad J, Ali A, Khan S
IET Syst Biol. 2020; 14(2):47-58.
PMID: 32196463
PMC: 8687251.
DOI: 10.1049/iet-syb.2019.0032.
RAD genotyping reveals fine-scale population structure and provides evidence for adaptive divergence in a commercially important fish from the northwestern Pacific Ocean.
Zhang B, Xue D, Li Y, Liu J
PeerJ. 2019; 7:e7242.
PMID: 31309001
PMC: 6612258.
DOI: 10.7717/peerj.7242.
The Zinc Transporter Zip7 Is Downregulated in Skeletal Muscle of Insulin-Resistant Cells and in Mice Fed a High-Fat Diet.
Norouzi S, Adulcikas J, Henstridge D, Sonda S, Sohal S, Myers S
Cells. 2019; 8(7).
PMID: 31266232
PMC: 6678147.
DOI: 10.3390/cells8070663.
Therapeutic effects of ethanolic extract from the green cocoon shell of silkworm on type 2 diabetic mice and its hypoglycaemic mechanism.
Zhao J, Wang H, Wei Z, Zhang Y
Toxicol Res (Camb). 2019; 8(3):407-420.
PMID: 31160974
PMC: 6505391.
DOI: 10.1039/c8tx00294k.
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications.
Nagappan A, Shin J, Jung M
Int J Mol Sci. 2019; 20(9).
PMID: 31035653
PMC: 6540410.
DOI: 10.3390/ijms20092109.
The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4.
Funk N, Munz M, Ott T, Brockmann K, Wenninger-Weinzierl A, Kuhn R
Sci Rep. 2019; 9(1):4515.
PMID: 30872638
PMC: 6418296.
DOI: 10.1038/s41598-019-40808-y.
Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
Pan W, Zeng J, Wen D, Wang J, Wang P, Chen G
Oncol Lett. 2019; 17(2):1695-1713.
PMID: 30675229
PMC: 6341845.
DOI: 10.3892/ol.2018.9748.
Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific.
Guerrini V, Prideaux B, Blanc L, Bruiners N, Arrigucci R, Singh S
PLoS Pathog. 2018; 14(8):e1007223.
PMID: 30161232
PMC: 6117085.
DOI: 10.1371/journal.ppat.1007223.
Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice.
Villa-Perez P, Merino B, Fernandez-Diaz C, Cidad P, Lobaton C, Moreno A
Metabolism. 2018; 88:1-11.
PMID: 30098324
PMC: 6185772.
DOI: 10.1016/j.metabol.2018.08.001.
